Literature DB >> 21320727

The association between verbal memory, processing speed, negative symptoms and functional capacity in schizophrenia.

Joan McDowd1, Tze-Chun Tang, Pei-Chun Tsai, Shing-Yaw Wang, Chwen-Yng Su.   

Abstract

The aim of this paper is to explore the links among verbal memory, processing speed, negative symptoms, and functional capacity, using structural equation modeling techniques. Model A is a multiple regression model with cognitive and symptom variables as predictors and functional capacity as the latent outcome variable. Model B consists of three two mediator models that assess the ability of each variable to mediate the effect of the other variable on outcome conditional on the inclusion of the other mediator in the model. Ninety-eight community-dwelling patients with schizophrenia (mean age=35.8years, S.D.=10.1) participated in the study. Results indicate that verbal memory, processing speed and negative symptoms significantly contributed to functional status. Verbal memory was at least partially mediated by processing speed in its effect on outcome, while the impact of processing speed on outcome was mediated by both verbal memory and negative symptoms. The influence of negative symptoms on functional capacity was partially mediated by processing speed. These findings enrich our understanding of the direct and indirect effects of these three interrelated variables and provide a basis for the development of intervention strategies.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21320727     DOI: 10.1016/j.psychres.2011.01.017

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  9 in total

1.  FDG-PET scans in patients with Kraepelinian and non-Kraepelinian schizophrenia.

Authors:  Marie-Cécile Bralet; Monte S Buchsbaum; Alex DeCastro; Lina Shihabuddin; Serge A Mitelman
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-09-14       Impact factor: 5.270

2.  General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia.

Authors:  János M Réthelyi; Pál Czobor; Patrícia Polgár; Beatrix Mersich; Sára Bálint; Eva Jekkel; Krisztina Magyar; Agnes Mészáros; Agnes Fábián; István Bitter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-07-27       Impact factor: 5.270

3.  Deconstructing Negative Symptoms in Individuals at Clinical High-Risk for Psychosis: Evidence for Volitional and Diminished Emotionality Subgroups That Predict Clinical Presentation and Functional Outcome.

Authors:  Tina Gupta; Henry R Cowan; Gregory P Strauss; Elaine F Walker; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

4.  A case control study of association between cognition and functional capacity in schizophrenia.

Authors:  Sreelatha S Narayanan; Triptish Bhatia; Dawn I Velligan; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Schizophr Res       Date:  2015-10-31       Impact factor: 4.939

5.  Preserved Learning during the Symbol-Digit Substitution Test in Patients with Schizophrenia, Age-Matched Controls, and Elderly.

Authors:  Claudia Cornelis; Livia J De Picker; Wouter Hulstijn; Glenn Dumont; Maarten Timmers; Luc Janssens; Bernard G C Sabbe; Manuel Morrens
Journal:  Front Psychiatry       Date:  2015-01-06       Impact factor: 4.157

6.  Clinical correlates of parametric digit-symbol substitution test in schizophrenia.

Authors:  Anekal C Amaresha; Vijay Danivas; Venkataram Shivakumar; Sri Mahavir Agarwal; Sunil V Kalmady; Janardhanan C Narayanaswamy; Ganesan Venkatasubramanian
Journal:  Asian J Psychiatr       Date:  2014-05-09

7.  The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia.

Authors:  Xing-Jie Peng; Gang-Rui Hei; Ye Yang; Chen-Chen Liu; Jing-Mei Xiao; Yu-Jun Long; Jing Huang; Jing-Ping Zhao; Ren-Rong Wu
Journal:  Front Psychiatry       Date:  2021-02-25       Impact factor: 4.157

8.  Influence of Antipsychotic and Anticholinergic Loads on Cognitive Functions in Patients with Schizophrenia.

Authors:  Michael Rehse; Marina Bartolovic; Katlehn Baum; Dagmar Richter; Matthias Weisbrod; Daniela Roesch-Ely
Journal:  Schizophr Res Treatment       Date:  2016-04-10

9.  Persistent negative symptoms in individuals at Ultra High Risk for psychosis.

Authors:  Alison R Yung; Barnaby Nelson; Patrick D McGorry; Stephen J Wood; Ashleigh Lin
Journal:  Schizophr Res       Date:  2018-10-26       Impact factor: 4.939

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.